News

  • All
  • Asylia News
  • Nirogy News
  • Press Release
  • Sporos News
  • Stellanova News
  • Tvardi News
Sporos News

Sporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive Officer

Read More →
Tvardi Therapeutics
Tvardi News

Tvardi Therapeutics Raises $74 Million in Series B Financing to Advance Clinical Programs

Read More →
Stellanova Therapeutics
Press Release

Stellanova Therapeutics, Inc. Announces Closing of $15.5 Million Series A Financing

Read More →
Asylia Therapeutics News
Asylia News

Asylia Therapeutics, Inc. Announces Closing of $14.5 Million Series A Financing

Read More →
Sporos News

Sporos Launches with $38.1 Million Series A Financing

Read More →
Nirogy News

Nirogy Therapeutics to Present at AACR Annual Meeting 2021

Read More →
Asylia Therapeutics News
Asylia News

JLABS @ TMC and Asylia Therapeutics on Navigating a Powerful Tool: The Human Immune System

Read More →
Nirogy News

Nirogy Therapeutics Launches with $16.5 Million Series A Financing

Read More →
Tvardi Therapeutics
Tvardi News

Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum

Read More →
Asylia Therapeutics News
Asylia News

New Company Asylia Therapeutics Finalizes Exclusive Worldwide License Agreement

Read More →
Tvardi Therapeutics
Tvardi News

Tvardi Therapeutics Announces Publication Demonstrating TTI-101 as a Therapeutic Option for Treatment-Resistant Breast Cancers

Read More →
Tvardi Therapeutics
Tvardi News

Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research

Read More →
Scroll to Top